beta

DERM

Dermira, Inc.

Derm

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.

Market Cap: 438 Million

Primary Exchange: NASDAQ

Website: http://www.dermira.com

Shares Outstanding: 54.5 Million

Float: 45.1 Million

Dividend: (%)

Beta: 1.12958209790983

Sector: Health Technology

Industry: Biotechnology

Short Interest (Jan 12, 2018): 3.94 Million

Ethical Flags

Animal testing

Longest drawdown: 687 trading days

From: 2017-03-06 To: 2019-11-12

Lowest Point:

Dermira to Present at the Raymond James Life Sciences and MedTech Conference

via: Business Wire at 2019-06-11 12:00:00:000

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that company management will present at the Ra… read more...

Dermira to Present at the Raymond James Life Sciences and MedTech Conference

via: Business Wire at 2019-06-11 12:00:00:000

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that company management will present at the Ra… read more...

Dermira to Present at the Raymond James Life Sciences and MedTech Conference

via: Business Wire at 2019-06-11 12:00:00:000

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that company management will present at the Ra… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud